• info@cats-foundation.org
Cure and Action for Tay-Sachs (CATS) Foundation
Cure and Action for Tay-Sachs (CATS) Foundation
Facebook Twitter Instagram Linkedin Youtube
Donate Now
  1. Home
  2. Uncategorized
DanielLewi
Uncategorized

GM2 Gangliosidosis Community Response to the FDA regarding AQNEURSA

GM2 Gangliosidosis Community Response – FDA CRL NALL for GM2Download

You can read our letter to the FDA by clicking on the file.

DanielLewi

Add a Comment

Your email address will not be published.

All Categories

Recent Posts

DanielLewi0 Comments

GM2 Gangliosidosis Community Response to the FDA regarding AQNEURSA

DanielLewi0 Comments

The CATS Foundation’s “Spot the Stop” Campaign Wins Bronze at PM Society Digital Awards

DanielLewi0 Comments

Azafaros press release:  Azafaros announces positive topline Phase 2 study data with nizubaglustat in GM2 gangliosidosis and Niemann-Pick disease type C

Tags
Awards blog conference events FDA podcast posters publication registry Research research announcement research update spot the stop trial

Give them a helping hand

Support our community by making a donation
Donate

+44 7894 859 752

info@cats-foundation.org

Contact us